These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9043842)

  • 1. Prognostic value of plasma endothelin-1 in patients with chronic heart failure.
    Pousset F; Isnard R; Lechat P; Kalotka H; Carayon A; Maistre G; Escolano S; Thomas D; Komajda M
    Eur Heart J; 1997 Feb; 18(2):254-8. PubMed ID: 9043842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
    Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
    Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
    Pacher R; Stanek B; Hülsmann M; Koller-Strametz J; Berger R; Schuller M; Hartter E; Ogris E; Frey B; Heinz G; Maurer G
    J Am Coll Cardiol; 1996 Mar; 27(3):633-41. PubMed ID: 8606275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levels of adrenomedullin in plasma of patients with chronic congestive heart failure].
    Halawa B; Mazurek W
    Pol Arch Med Wewn; 1998 Jan; 99(1):2-8. PubMed ID: 9686497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure.
    Pousset F; Masson F; Chavirovskaia O; Isnard R; Carayon A; Golmard JL; Lechat P; Thomas D; Komajda M
    Eur Heart J; 2000 Jun; 21(12):1009-14. PubMed ID: 10901513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.
    Van Beneden R; Gurné O; Selvais PL; Ahn SA; Robert AR; Ketelslegers JM; Pouleur HG; Rousseau MF
    J Card Fail; 2004 Dec; 10(6):490-5. PubMed ID: 15599839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity.
    Madsen BK; Keller N; Christiansen E; Christensen NJ
    J Card Fail; 1995 Jun; 1(3):207-16. PubMed ID: 9420653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
    Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
    Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines and remodeling of the heart in patients with congestive heart failure].
    Jołda-Mydłowska B; Salomon P
    Pol Arch Med Wewn; 2003 Jan; 109(1):23-33. PubMed ID: 12879763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum cytokines in patients with congestive heart failure.
    Orús J; Roig E; Perez-Villa F; Paré C; Azqueta M; Filella X; Heras M; Sanz G
    J Heart Lung Transplant; 2000 May; 19(5):419-25. PubMed ID: 10808148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
    Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Mabuchi N; Hayashi M; Ohnishi M; Sawaki M; Fujii M; Horie H; Sugimoto Y; Kinoshita M
    Eur Heart J; 1999 Dec; 20(24):1799-807. PubMed ID: 10581138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma concentrations of endothelin in congestive heart failure in humans.
    Rodeheffer RJ; Lerman A; Heublein DM; Burnett JC
    Mayo Clin Proc; 1992 Aug; 67(8):719-24. PubMed ID: 1434909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.